An observational study in Neonatal Delirium, sponsored by Copenhagen University Hospital, Rigshospitalet. Not yet recruiting. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Copenhagen University Hospital, Rigshospitalet · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The CLEAR-NEO study is an international multicenter observational study designed to estimate the prevalence of neonatal delirium among critically ill neonates admitted to neonatal intensive care units (NICUs). Participating NICUs will perform standardized delirium assessments using the Cornell Assessment of Pediatric Delirium (CAPD) on three designated study days. The study aims to determine the point prevalence of neonatal delirium.
Neonatal delirium is increasingly recognized as a neurocognitive complication of critical illness, but knowledge regarding its prevalence in neonatal intensive care units (NICUs) remains limited. Existing studies have been small, single-center investigations, and reported prevalence estimates vary considerably. Large international epidemiological studies of neonatal delirium have not previously been conducted.
The International Clinical Epidemiology and Assessment of prevalence Rates of delirium in NEOnates (CLEAR-NEO) study is an international multicenter observational point prevalence study designed to estimate the prevalence of neonatal delirium among critically ill neonates admitted to NICUs. Participating sites will be recruited internationally through neonatal and pediatric critical care research networks and professional organizations.
On three predefined study days, eligible neonates with a postmenstrual age of 34+0 to 44+0 weeks who have been admitted to a participating NICU for at least 48 hours will undergo delirium assessment using the Cornell Assessment of Pediatric Delirium (CAPD). Neonates will be classified as delirium-positive when at least one CAPD assessment performed on the study day yields a score of 9 or higher.
In addition to delirium assessments, participating sites will provide aggregated data regarding patient characteristics, clinical variables, and NICU characteristics. No patient-identifiable information or individual patient-level data will be transferred to the coordinating center. Data will be entered into a secure REDCap database hosted by Copenhagen University Hospital Rigshospitalet.
The primary objective is to estimate the international point prevalence of neonatal delirium among critically ill neonates admitted to NICUs. Secondary objectives include describing delirium subtypes and characterizing participating NICUs and patient populations.
935 studies on the registry are indexed under Delirium; 188 are open to participants now.
This study's planned enrollment of 500 is above the median of 196 across 343 observational studies indexed under Delirium.
Browse Delirium studies →Copenhagen University Hospital, Rigshospitalet is the lead sponsor of 46 studies on the registry; 21 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Neonates admitted to participating neonatal intensive care units (NICUs). Eligible participants have a postmenstrual age of 34+0 to 44+0 weeks and have been admitted to the NICU for at least 48 hours at the time of assessment. Participating sites are recruited internationally and include NICUs of different levels of care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Neonates with a postmenstrual age of 34+0 to 44+0 weeks admitted to participating neonatal intensive care units (NICUs) for at least 48 hours at the time of assessment. Participants undergo delirium assessment using the Cornell Assessment of Pediatric Delirium (CAPD) as part of an international multicenter observational point prevalence study.
Prevalence of Neonatal Delirium
Proportion of eligible neonates classified as delirium-positive, defined as at least one Cornell Assessment of Pediatric Delirium (CAPD) score ≥9 on the study day.
Time frame: Study day (March 10, April 7, or May 5, 2027)
No study locations are listed for this record.
Plan to share: No — Only aggregated data will be entered into the study database. No patient-identifiable information or individual participant-level data will be transferred between participating sites or entered into the central database.
No publications or documents are linked to this record.
Start is estimated for Mar 2027; primary completion for Apr 2027, 0 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Copenhagen University Hospital, Rigshospitalet